MATX

MATX Operating Cash Flow (Statement)

$582.00MTTM · USD

Period ending:

MATX FY Cash from OperationsUSD
MATX FY Cash from Operations1989-12-31: $97.40M1990-12-31: $135.20M1991-12-31: $171.60M1992-12-31: $157.50M1993-12-31: $192.90M1994-12-31: $186.76M1995-12-31: $71.66M1996-12-31: $133.00M1997-12-31: $181.87M1998-12-31: $135.27M1999-12-31: $109.38M2000-12-31: $104.28M2001-12-31: $150.97M2002-12-31: $56.00M2003-12-31: $136.00M2004-12-31: $173.00M2005-12-31: $278.00M2006-12-31: $106.00M2007-12-31: $124.00M2008-12-31: $275.00M2009-12-31: $115.00M2010-12-31: $150.00M2011-12-31: $86.00M2012-12-31: $64.10M2013-12-31: $195.70M2014-12-31: $165.70M2015-12-31: $245.30M2016-12-31: $157.80M2017-12-31: $224.90M2018-12-31: $305.00M2019-12-31: $248.80M2020-12-31: $429.80M2021-12-31: $984.10M2022-12-31: $1.27B2023-12-31: $510.50M2024-12-31: $767.80M2025-12-31: $545.00M$1.27B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MATX operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Matson Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
545,000,000
767,800,000
510,500,000
1,271,900,000
984,100,000
429,800,000
248,800,000
305,000,000
224,900,000
157,800,000
245,300,000
165,700,000
195,700,000
64,100,000
86,000,000
150,000,000
115,000,000
275,000,000
124,000,000
106,000,000
278,000,000
173,000,000
136,000,000
56,000,000
150,968,000
104,278,000
109,379,000
135,272,000
181,869,000
133,002,000
71,656,000
186,761,000
192,900,000
157,500,000
171,600,000
135,200,000
97,400,000

Compare operating cash flow (statement)

All MATX financial metrics · MATX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.